Your browser doesn't support javascript.
loading
E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.
Claudiani, Simone; Apperley, Jane F; Gale, Robert Peter; Clark, Richard; Szydlo, Richard; Deplano, Simona; Palanicawandar, Renuka; Khorashad, Jamshid; Foroni, Letizia; Milojkovic, Dragana.
Afiliación
  • Claudiani S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London Simone.Claudiani@imperial.nhs.uk.
  • Apperley JF; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Gale RP; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Clark R; Royal Liverpool University Hospital, UK.
  • Szydlo R; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Deplano S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Palanicawandar R; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Khorashad J; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Foroni L; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
  • Milojkovic D; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
Haematologica ; 102(8): e297-e299, 2017 08.
Article en En | MEDLINE | ID: mdl-28495914
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ARN Neoplásico / Leucemia Mielógena Crónica BCR-ABL Positiva / Privación de Tratamiento / Inhibidores de Proteínas Quinasas Tipo de estudio: Risk_factors_studies Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ARN Neoplásico / Leucemia Mielógena Crónica BCR-ABL Positiva / Privación de Tratamiento / Inhibidores de Proteínas Quinasas Tipo de estudio: Risk_factors_studies Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article